The 2026 Dyslipidemia Guidelines Playbook: From Evidence to Action

Join host Dr. Keerthana Pakanati for an in-depth discussion with two leaders in preventive cardiology, Dr. Roger Blumenthal and Dr. Ty Gluckman, as they break down the highly anticipated 2026 ACC/AHA/Multisociety Dyslipidemia Guidelines.

In this episode, the panel explores the biggest updates shaping lipid management today, including LDL-C targets, the PREVENT risk score, coronary artery calcium (CAC), Lp(a), apoB, and the evolving role of personalized risk assessment. The conversation also dives into practical strategies for applying the guidelines in real-world clinical practice, navigating treatment barriers, and improving long-term cardiovascular prevention.

Listeners will gain expert insight into:

• Key changes in the 2026 dyslipidemia guidelines

• Treat-to-target vs. threshold-based therapy

• Risk stratification using PREVENT, CAC, Lp(a), and apoB

• Lipid management in women and younger patients

• Cost, access, adherence, and emerging therapies

• The future of preventive cardiology and systems-based care

A must-listen episode for clinicians, trainees, and anyone passionate about advancing cardiovascular prevention.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.